Tianjin authorities visit Danish company鈥檚 production site
Print Edition
Chinese authorities have visited a site operated by Danish drugmaker Novo Nordisk A/S, the world’s biggest maker of insulin, the latest development in a widening investigation into Western drugmakers.
Novo said officials from the local Administration for Industry and Commerce visited a production facility in Tianjin on August 1.
“We were asked to provide information regarding our operations in China,” Chief Financial Officer Jesper Brandgaard said yesterday.
He said that whether it was a routine check, or triggered by the GSK investigation, was not clear. However, there had been no suggestions of any wrongdoing, he claimed.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
